TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven

Michael Wiggins De OliveiraInvesting Group LeaderFollow5ShareSavePlay(10min)CommentsSummaryTransMedics is positioned for accelerating growth, with revenue expected to expand around 25% in 2026 and free cash flow breakeven by late 2026 or early 2027.TMDX is over the crest of its capex cycle, with investment pressures expected to ease, supporting margin expansion toward a 30% target by 2028.Despite a weak balance sheet and potential for 15% shareholder dilution in 2026, I remain bullish as long as revenue growth stays above 20% y/y.The market's short-term focus overlooks TMDX's long-term growth trajectory, robust operating leverage, and AI-immune business model.Looking for a helping hand in the market? Members of Deep Value Returns get exclusive ideas and guidance to navigate any climate. Learn More » sturti/E+ via Getty Images Dear Readers, You can read my previous analysis of TransMedics here for free. Previously, I held no position, but now I do; hence, I'm clearly more bullish.

Investment Thesis TransMedics (TMDX) is a rapidlyThis article was written byMichael Wiggins De Oliveira52.56K FollowersFollowMichael Wiggins De Oliveira is an Inflection investor. As an Inflection investor, I believe that simplicity is key to outperformance. Since 2024, Deep Value Returns is up 174% vs 58% for the Nasdaq (*as of 6 January 2026).This means buying a stock at the moment when the outlook is expected to improve over the next year. This allows one to minimize the downside, while positioning yourself at the moment when the stock is primed to perform strongly.With a focus on tech and “the Great Energy Transition (including uranium)”, Michael runs a concentrated portfolio with approximately 15 to 20 stocks and an average holding period of 18 months. Through his 10+ years analyzing countless companies, Michael has accumulated outstanding professional experience in tech and energy and a following of over 40K on Seeking Alpha.Michael is the leader of the Investing Group Deep Value Returns.Features of the group include: Insights through his concentrated portfolio of Inflection stocks, timely updates on stock picks, and "hand-holding" as-needed for new and experienced investors alike.

Deep Value Returns also has an active, vibrant, and kind community easily accessible via chat. Learn moreAnalyst’s Disclosure: I/we have a beneficial long position in the shares of TMDX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.